中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 2
Feb.  2024
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(2): 319-326

Proteomic analysis and validation of DNA repair regulation in the process of hepatocellular carcinoma recurrence

DOI: 10.12449/JCH240216
  • 1.

    Department of Clinical Laboratory，The General Hospital of Western Theater Command，Chengdu 610083，China

  • 2.

    Department of Medical Laboratory，Affiliated Cancer Hospital of Chengdu Medical College，Chengdu Seventh People’s Hospital，Chengdu 610041，China

  • 3.

    Institute of Microbiology，Sichuan Provincial Center for Disease Control and Prevention，Chengdu 610041，China

  • 4.

    Biology Teaching and Research Group，Chengdu Experimental Foreign Languages School，Chengdu 611134，China

  • 5.

    College of Pharmaceutical Sciences/School of Traditional Chinese Medicine，Southwest University，Chongqing 400715，China

Research funding:

Natural Science Foundation of Sichuan Province (2022NSFSC1415);

The Special Project of Sichuan Province Traditional Chinese Medicine Administration (2020JC0124);

The Management Project of General Hospital of Western Theater Comm (2021-XZYG-C22);

The Management Project of General Hospital of Western Theater Comm (2021-XZYG-C21);

The Spark Young Innovative Talent Project of General Hospital of Western Theater Command 

More Information
  • Corresponding author: LIU Yuan， liuyuan198231@163.com （ORCID： 0000-0002-1574-0242）; CHEN Min， mminchen@swu.edu.cn （ORCID： 0000-0002-0140-4192）
  • Received Date: 2023-05-04
  • Accepted Date: 2023-05-29
  • Published Date: 2024-02-19
    Abstract
  •   Objective  To investigate the role and mechanism of DNA repair regulation in the process of hepatocellular carcinoma （HCC） recurrence.  Methods  HCC tissue samples were collected from the patients with recurrence within two years or the patients with a good prognosis after 5 years， and the Tandem Mass Tag-labeled quantification proteomic study was used to analyze the differentially expressed proteins enriched in the four pathways of DNA replication， mismatch repair， base excision repair， and nucleotide excision repair， and the regulatory pathways and targets that play a key role in the process of HCC recurrence were analyzed to predict the possible regulatory mechanisms. The independent samples t-test was used for comparison of continuous data between two groups； a one-way analysis of variance was used for comparison between multiple groups， and the least significant difference t-test was used for further comparison between two groups.  Results  For the eukaryotic replication complex pathway， there were significant reductions in the protein expression levels of MCM2 （P=0.018）， MCM3 （P=0.047）， MCM4 （P=0.014）， MCM5 （P=0.008）， MCM6 （P=0.006）， MCM7 （P=0.007）， PCNA （P=0.019）， RFC4 （P=0.002）， RFC5 （P<0.001）， and LIG1 （P=0.042）； for the nucleotide excision repair pathway， there were significant reductions in the protein expression levels of PCNA （P=0.019）， RFC4 （P=0.002）， RFC5 （P<0.001）， and LIG1 （P=0.042）； for the base excision repair pathway， there were significant reductions in the protein expression levels of PCNA （P=0.019） and LIG1 （P=0.042） in the HCC recurrence group； for the mismatch repair pathway， there were significant reductions in the protein expression levels of MSH2 （P=0.026）， MSH6 （P=0.006）， RFC4 （P=0.002）， RFC5 （P<0.001）， PCNA （P=0.019）， and LIG1 （P=0.042） in recurrent HCC tissue. The differentially expressed proteins were involved in the important components of MCM complex， DNA polymerase complex， ligase LIG1， long patch base shear repair complex （long patch BER）， and DNA mismatch repair protein complex. The clinical sample validation analysis of important differentially expressed proteins regulated by DNA repair showed that except for MCM6 with a trend of reduction， the recurrence group also had significant reductions in the relative protein expression levels of MCM5 （P=0.008）， MCM7 （P=0.007）， RCF4 （P=0.002）， RCF5 （P<0.001）， and MSH6 （P=0.006）.  Conclusion  There are significant reductions or deletions of multiple complex protein components in the process of DNA repair during HCC recurrence.

     

    • FullText(HTML)
  • loading
    • References(17)
  • [1]
    HU ZQ, YIN YF, JIANG J, et al. Exosomal miR-142-3p secreted by hepatitis B virus(HBV)-hepatocellular carcinoma(HCC) cells promotes ferroptosis of M1-type macrophages through SLC3A2 and the mechanism of HCC progression[J]. J Gastrointest Oncol, 2022, 13( 2): 754- 767. DOI: 10.21037/jgo-21-916.
    [2]
    KATO K, FUKAI M, HATANAKA KC, et al. Versican secreted by cancer-associated fibroblasts is a poor prognostic factor in hepatocellular carcinoma[J]. Ann Surg Oncol, 2022, 29( 11): 7135- 7146. DOI: 10.1245/s10434-022-11862-0.
    [3]
    PANG SJ, SHI Y, XU DP, et al. Screening of hepatocellular carcinoma patients with high risk of early recurrence after radical hepatectomy using a nomogram model based on the γ‍-glutamyl transpeptidase-to-albumin ratio[J]. J Gastrointest Surg, 2022, 26( 8): 1- 9. DOI: 10.1007/s11605-022-05326-9.
    [4]
    GOMEZ-QUIROZ LE, ROMAN S. Influence of genetic and environmental risk factors in the development of hepatocellular carcinoma in Mexico[J]. Ann Hepatol, 2022, 27( Suppl 1): 100649. DOI: 10.1016/j.aohep.2021.100649.
    [5]
    LUO MJ, ZHAO YX, WANG YD, et al. Comparative proteomics of contrasting maize genotypes provides insights into salt-stress tolerance mechanisms[J]. J Proteome Res, 2018, 17( 1): 141- 153. DOI: 10.1021/acs.jproteome.7b00455.
    [6]
    SHRESTHA P, KIM MS, ELBASANI E, et al. Prediction of trehalose-metabolic pathway and comparative analysis of KEGG, MetaCyc, and RAST databases based on complete genome of Variovorax sp. PAMC28711[J]. BMC Genom Data, 2022, 23( 1): 4. DOI: 10.1186/s12863-021-01020-y.
    [7]
    MURANUSHI R, ARAKI K, YOKOBORI T, et al. High membrane expression of CMTM6 in hepatocellular carcinoma is associated with tumor recurrence[J]. Cancer Sci, 2021, 112( 8): 3314- 3323. DOI: 10.1111/cas.15004.
    [8]
    ZHONG F, XIE C, PENG X, et al. A commentary on‘Laparoscopic versus open repeat hepatectomy for recurrent hepatocellular carcinoma: A systematic review and meta-analysis of propensity score-matched cohort studies’[J]. Int J Surg, 2023, 109( 9): 2821- 2822. DOI: 10.1097/js9.0000000000000517.
    [9]
    BAI YP, SHA JJ, OKUI T, et al. The epithelial-mesenchymal transition influences the resistance of oral squamous cell carcinoma to monoclonal antibodies via its effect on energy homeostasis and the tumor microenvironment[J]. Cancers, 2021, 13( 23): 5905. DOI: 10.3390/cancers13235905.
    [10]
    HUANG DP, LIAO MM, TONG JJ, et al. Construction of a genome instability-derived lncRNA-based risk scoring system for the prognosis of hepatocellular carcinoma[J]. Aging, 2021, 13( 22): 24621- 24639. DOI: 10.18632/aging.203698.
    [11]
    CHEN Y, HUANG MJ, ZHU JK, et al. Identification of a DNA damage response and repair-related gene-pair signature for prognosis stratification analysis in hepatocellular carcinoma[J]. Front Pharmacol, 2022, 13: 857060. DOI: 10.3389/fphar.2022.857060.
    [12]
    BARCENA-VARELA M, LUJAMBIO A. A novel long noncoding RNA finetunes the DNA damage response in hepatocellular carcinoma[J]. Cancer Res, 2021, 81( 19): 4899- 4900. DOI: 10.1158/0008-5472.CAN-21-2776.
    [13]
    WANG ZY, WANG XX, RONG ZH, et al. LncRNA LINC01134 contributes to radioresistance in hepatocellular carcinoma by regulating DNA damage response via MAPK signaling pathway[J]. Front Pharmacol, 2022, 12: 791889. DOI: 10.3389/fphar.2021.791889.
    [14]
    LIU HH, YAN YC, CHEN RB, et al. Integrated nomogram based on five stage-related genes and TNM stage to predict 1-year recurrence in hepatocellular carcinoma[J]. Cancer Cell Int, 2020, 20: 140. DOI: 10.1186/s12935-020-01216-9.
    [15]
    MARSHALL AE, RUSHBROOK SM, VOWLER SL, et al. Tumor recurrence following liver transplantation for hepatocellular carcinoma: Role of tumor proliferation status[J]. Liver Transpl, 2010, 16( 3): 279- 288. DOI: 10.1002/lt.21993.
    [16]
    LIAO XW, LIU XG, YANG CK, et al. Distinct diagnostic and prognostic values of minichromosome maintenance gene expression in patients with hepatocellular carcinoma[J]. J Cancer, 2018, 9( 13): 2357- 2373. DOI: 10.7150/jca.25221.
    [17]
    THUL PJ, LINDSKOG C. The human protein atlas: A spatial map of the human proteome[J]. Protein Sci, 2018, 27( 1): 233- 244. DOI: 10.1002/pro.3307.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(9)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (315) PDF downloads(48) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return